CLBT Valuation

Cellebrite DI Ltd

Add to Watchlist

Advanced Chart

16.400

-0.31(-1.855%)1D

Overview
Forecast
Valuation
Earnings

CLBT Relative Valuation

CLBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CLBT is overvalued; if below, it's undervalued.

Historical Valuation

Cellebrite DI Ltd (CLBT) is now in the Fair zone, suggesting that its current forward PE ratio of 33.33 is considered Fairly compared with the five-year average of 46.46. The fair price of Cellebrite DI Ltd (CLBT) is between 11.82 to 31.63 according to relative valuation methord.

Relative Value

Fair Zone

11.82-31.63

Current Price：16.71

Fair

32.71

Trailing

Forward

26.96

EV/EBITDA

Cellebrite DI Ltd. (CLBT) has a current EV/EBITDA of 26.96. The 5-year average EV/EBITDA is 26.02. The thresholds are as follows: Strongly Undervalued below -0.71, Undervalued between -0.71 and 12.65, Fairly Valued between 39.38 and 12.65, Overvalued between 39.38 and 52.74, and Strongly Overvalued above 52.74. The current Forward EV/EBITDA of 26.96 falls within the Historic Trend Line -Fairly Valued range.

28.58

EV/EBIT

Cellebrite DI Ltd. (CLBT) has a current EV/EBIT of 28.58. The 5-year average EV/EBIT is 31.59. The thresholds are as follows: Strongly Undervalued below -6.11, Undervalued between -6.11 and 12.74, Fairly Valued between 50.43 and 12.74, Overvalued between 50.43 and 69.28, and Strongly Overvalued above 69.28. The current Forward EV/EBIT of 28.58 falls within the Historic Trend Line -Fairly Valued range.

8.03

Cellebrite DI Ltd. (CLBT) has a current PS of 8.03. The 5-year average PS is 5.07. The thresholds are as follows: Strongly Undervalued below 0.04, Undervalued between 0.04 and 2.56, Fairly Valued between 7.59 and 2.56, Overvalued between 7.59 and 10.10, and Strongly Overvalued above 10.10. The current Forward PS of 8.03 falls within the Overvalued range.

24.80

P/OCF

Cellebrite DI Ltd. (CLBT) has a current P/OCF of 24.80. The 5-year average P/OCF is 24.28. The thresholds are as follows: Strongly Undervalued below 3.35, Undervalued between 3.35 and 13.81, Fairly Valued between 34.75 and 13.81, Overvalued between 34.75 and 45.21, and Strongly Overvalued above 45.21. The current Forward P/OCF of 24.80 falls within the Historic Trend Line -Fairly Valued range.

26.19

P/FCF

Cellebrite DI Ltd. (CLBT) has a current P/FCF of 26.19. The 5-year average P/FCF is 25.76. The thresholds are as follows: Strongly Undervalued below 1.69, Undervalued between 1.69 and 13.73, Fairly Valued between 37.79 and 13.73, Overvalued between 37.79 and 49.82, and Strongly Overvalued above 49.82. The current Forward P/FCF of 26.19 falls within the Historic Trend Line -Fairly Valued range.

Cellebrite DI Ltd (CLBT) has a current Price-to-Book (P/B) ratio of 10.00. Compared to its 3-year average P/B ratio of 8.43 , the current P/B ratio is approximately 18.66% higher. Relative to its 5-year average P/B ratio of 4.89, the current P/B ratio is about 104.47% higher. Cellebrite DI Ltd (CLBT) has a Forward Free Cash Flow (FCF) yield of approximately 3.73%. Compared to its 3-year average FCF yield of 3.23%, the current FCF yield is approximately 15.59% lower. Relative to its 5-year average FCF yield of 3.55% , the current FCF yield is about 4.90% lower.

9.82

P/B

Median3y

8.43

Median5y

4.89

3.68

FCF Yield

Median3y

3.23

Median5y

3.55

Competitors Valuation Multiple

The average P/S ratio for CLBT's competitors is 5.12, providing a benchmark for relative valuation. Cellebrite DI Ltd Corp (CLBT) exhibits a P/S ratio of 8.03, which is 56.80% above the industry average. Given its robust revenue growth of 18.35%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Dun & Bradstreet Holdings Inc

Performance Decomposition

Market capitalization of CLBT decreased by 3.87% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -10.12 to -24.98.

The secondary factor is the Revenue Growth, contributed 18.35%to the performance.

Overall, the performance of CLBT in the past 1 year is driven by P/E Change. Which is more unsustainable.

18.35%

95.71M → 113.28M

Revenue Growth

-169.09%

-24.88 → 17.19

Margin Expansion

146.87%

-10.12 → -24.98

P/E Change

-3.87%